Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.21
+4.87 (2.08%)
AAPL  247.95
-0.40 (-0.16%)
AMD  259.18
+5.45 (2.15%)
BAC  51.78
-0.67 (-1.28%)
GOOG  328.44
-2.40 (-0.73%)
META  658.32
+10.69 (1.65%)
MSFT  466.64
+15.50 (3.44%)
NVDA  187.64
+2.80 (1.51%)
ORCL  177.04
-1.14 (-0.64%)
TSLA  448.68
-0.68 (-0.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.